Although some literature suggests that NETs are part of the interface between host immunity and cancer biology.14,15 This encourages researchers to determine whether P-selectin, NET, and MPO play a role as risk factors for VTE, especially DVT, in patients with malignancies who receive platinum-based chemotherapy. The gene discussed is MPO; the disease is deep vein thrombosis.